Literature DB >> 26158069

Glaucoma progression detection using nonlocal Markov random field prior.

Akram Belghith1, Christopher Bowd1, Felipe A Medeiros1, Madhusudhanan Balasubramanian2, Robert N Weinreb1, Linda M Zangwill1.   

Abstract

Glaucoma is neurodegenerative disease characterized by distinctive changes in the optic nerve head and visual field. Without treatment, glaucoma can lead to permanent blindness. Therefore, monitoring glaucoma progression is important to detect uncontrolled disease and the possible need for therapy advancement. In this context, three-dimensional (3-D) spectral domain optical coherence tomography (SD-OCT) has been commonly used in the diagnosis and management of glaucoma patients. We present a new framework for detection of glaucoma progression using 3-D SD-OCT images. In contrast to previous works that use the retinal nerve fiber layer thickness measurement provided by commercially available instruments, we consider the whole 3-D volume for change detection. To account for the spatial voxel dependency, we propose the use of the Markov random field (MRF) model as a prior for the change detection map. In order to improve the robustness of the proposed approach, a nonlocal strategy was adopted to define the MRF energy function. To accommodate the presence of false-positive detection, we used a fuzzy logic approach to classify a 3-D SD-OCT image into a "non-progressing" or "progressing" glaucoma class. We compared the diagnostic performance of the proposed framework to the existing methods of progression detection.

Entities:  

Keywords:  change detection; fuzzy logic classifier; glaucoma; nonlocal Markov field

Year:  2014        PMID: 26158069      PMCID: PMC4478777          DOI: 10.1117/1.JMI.1.3.034504

Source DB:  PubMed          Journal:  J Med Imaging (Bellingham)        ISSN: 2329-4302


  31 in total

1.  Glaucomatous progression in series of stereoscopic photographs and Heidelberg retina tomograph images.

Authors:  Neil O'Leary; David P Crabb; Steven L Mansberger; Brad Fortune; Michael D Twa; Michael J Lloyd; Aachal Kotecha; David F Garway-Heath; George A Cioffi; Chris A Johnson
Journal:  Arch Ophthalmol       Date:  2010-05

2.  An optimized blockwise nonlocal means denoising filter for 3-D magnetic resonance images.

Authors:  P Coupe; P Yger; S Prima; P Hellier; C Kervrann; C Barillot
Journal:  IEEE Trans Med Imaging       Date:  2008-04       Impact factor: 10.048

3.  Real-time three-dimensional Fourier-domain optical coherence tomography video image guided microsurgeries.

Authors:  Jin U Kang; Yong Huang; Kang Zhang; Zuhaib Ibrahim; Jaepyeong Cha; W P Andrew Lee; Gerald Brandacher; Peter L Gehlbach
Journal:  J Biomed Opt       Date:  2012-08       Impact factor: 3.170

4.  Diffuse retinal nerve fiber layer defects identification and quantification in thickness maps.

Authors:  Joong Won Shin; Ki Bang Uhm; Mincheol Seong; Yu Jeong Kim
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-17       Impact factor: 4.799

5.  Early Manifest Glaucoma Trial: design and baseline data.

Authors:  M C Leske; A Heijl; L Hyman; B Bengtsson
Journal:  Ophthalmology       Date:  1999-11       Impact factor: 12.079

6.  Primary open-angle glaucoma, intraocular pressure, and diabetes mellitus in the general elderly population. The Rotterdam Study.

Authors:  I Dielemans; P T de Jong; R Stolk; J R Vingerling; D E Grobbee; A Hofman
Journal:  Ophthalmology       Date:  1996-08       Impact factor: 12.079

7.  Heidelberg retina tomography and optical coherence tomography in normal, ocular-hypertensive, and glaucomatous eyes.

Authors:  A Mistlberger; J M Liebmann; D S Greenfield; M E Pons; S T Hoh; H Ishikawa; R Ritch
Journal:  Ophthalmology       Date:  1999-10       Impact factor: 12.079

8.  Macular and peripapillary retinal nerve fiber layer measurements by spectral domain optical coherence tomography in normal-tension glaucoma.

Authors:  Mincheol Seong; Kyung Rim Sung; Eun Hee Choi; Sung Yong Kang; Jung Woo Cho; Tae Woong Um; Yoon Jeon Kim; Seong Bae Park; Hun Eui Hong; Michael S Kook
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-15       Impact factor: 4.799

9.  Machine learning classifiers for glaucoma diagnosis based on classification of retinal nerve fibre layer thickness parameters measured by Stratus OCT.

Authors:  Dimitrios Bizios; Anders Heijl; Jesper Leth Hougaard; Boel Bengtsson
Journal:  Acta Ophthalmol       Date:  2010-01-08       Impact factor: 3.761

10.  Longitudinal analysis of progression in glaucoma using spectral-domain optical coherence tomography.

Authors:  Julia M Wessel; Folkert K Horn; Ralf P Tornow; Matthias Schmid; Christian Y Mardin; Friedrich E Kruse; Anselm G Juenemann; Robert Laemmer
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-05-01       Impact factor: 4.799

View more
  4 in total

1.  Effect of quantitative intraocular pressure reduction on visual field defect progression in normal tension glaucoma under medical therapy applying Markov model.

Authors:  Keiji Yoshikawa; Kazunori Santo; Hiroko Hizaki; Masayo Hashimoto
Journal:  Clin Ophthalmol       Date:  2018-08-30

Review 2.  Machine Learning Algorithms to Detect Subclinical Keratoconus: Systematic Review.

Authors:  Howard Maile; Ji-Peng Olivia Li; Daniel Gore; Marcello Leucci; Padraig Mulholland; Scott Hau; Anita Szabo; Ismail Moghul; Konstantinos Balaskas; Kaoru Fujinami; Pirro Hysi; Alice Davidson; Petra Liskova; Alison Hardcastle; Stephen Tuft; Nikolas Pontikos
Journal:  JMIR Med Inform       Date:  2021-12-13

3.  Individualized Glaucoma Change Detection Using Deep Learning Auto Encoder-Based Regions of Interest.

Authors:  Christopher Bowd; Akram Belghith; Mark Christopher; Michael H Goldbaum; Massimo A Fazio; Christopher A Girkin; Jeffrey M Liebmann; Carlos Gustavo de Moraes; Robert N Weinreb; Linda M Zangwill
Journal:  Transl Vis Sci Technol       Date:  2021-07-01       Impact factor: 3.048

4.  Structural Change Can Be Detected in Advanced-Glaucoma Eyes.

Authors:  Akram Belghith; Felipe A Medeiros; Christopher Bowd; Jeffrey M Liebmann; Christopher A Girkin; Robert N Weinreb; Linda M Zangwill
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-07-01       Impact factor: 4.799

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.